Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. (Q50929280)

25 March 2018

title

Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. (English)

1 reference

25 March 2018

main subject

ataxia telangiectasia

1 reference

Andreea Nissenkorn

1

1 reference

25 March 2018

Yael Levy-Shraga

2

1 reference

25 March 2018

Yonit Banet-Levi

3

1 reference

25 March 2018

Avishay Lahad

4

1 reference

25 March 2018

Ifat Sarouk

5

1 reference

25 March 2018

Dalit Modan-Moses

6

1 reference

25 March 2018

language of work or name

English

0 references

publication date

18 February 2016

1 reference

25 March 2018

published in

Pediatric Research

1 reference

25 March 2018

volume

79

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

889-894

1 reference

25 March 2018

Ataxia-telangiectasia, an evolving phenotype

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Louis-bar's syndrome (ataxia-telangiectasia). Neuropathologic observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Gonadal dysfunction in patients with ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Atm-deficient mice: a paradigm of ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Impaired insulin secretion in a mouse model of ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Neurodegeneration is associated to changes in serum insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

ATM controls meiotic double-strand-break formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Impaired insulin-stimulated glucose transport in ATM-deficient mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Clinical review 1: Bisphosphonate use in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Review: The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Does growth hormone cause cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Neurologic presentation in children with ataxia-telangiectasia: is small head circumference a hallmark of the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Comparison of body weight and height of Israeli schoolchildren with the Tanner and Centers for Disease Control and Prevention growth charts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Vitamin D deficiency in children and its management: review of current knowledge and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Lymphoid tissue abnormalities associated with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

31 March 2020

Ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Growth factor deficiency in patients with ataxia telangiectasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

An unusual form of diabetes mellitus in ataxia telangiectasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Ovarian Changes in Ataxia Telangiectasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.19

Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases

31 March 2020

1 reference

12 December 2020

Twenty-year follow-up of 160 patients with ataxia-telangiectasia

1 reference

12 December 2020

ATAXIA-TELANGIECTASIA. A CASE WITH LESIONS OF OVARIES AND ADENOHYPOPHYSIS

1 reference

12 December 2020

Ataxia-telangiectasia: some historic, clinical and pathologic observations

1 reference

12 December 2020

Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents

1 reference

12 December 2020

Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals

1 reference

12 December 2020

ATAXIA-TELANGIECTASIA

1 reference

12 December 2020

Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection.

1 reference

12 December 2020

Identifiers

DOI

10.1038/PR.2016.19

1 reference

25 March 2018

1 reference

25 March 2018